Navigation Links
Newly Updated Pharmacy State Law Compendium Available
Date:10/8/2009

CORAL SPRINGS, Fla., Oct. 8 /PRNewswire/ -- The most comprehensive, up-to-date compendium of state and federal pharmacy statutes and regulations is now available from Point of Care Partners (POCP), a nationally known boutique healthcare information technology (HIT) strategy and management consulting firm with expertise in ePrescribing, chronic care management, electronic health records, health information exchanges and personal health records.

The compendium, updated for the third quarter of 2009, is a must-have for clinical software companies; policymakers; intermediaries; retail, mail and specialty pharmacies, and others who need to have the latest state-specific information on the changing regulatory landscape affecting ePrescribing and the exchange of prescription information across state lines. The timing for this updated compendium has never been better, given the wide variations and constant realignment of requirements among jurisdictions and Boards of Pharmacy (BOP) and the growing use of ePrescribing and health information exchange within and across states.

"Our pharmacy law database is invaluable to help ensure that clients can comply with state and federal ePrescribing regulations," said Sherry L. Neumann, PharmD, an affiliated consultant with POCP who created the compendium and has updated it every quarter since 2006.

The new database has the most currently available information as of the third quarter of 2009, which is gleaned from BOP websites and other published materials, such as pharmacy association and BOP newsletters, state health and safety codes, and Medicaid rules and regulations (where applicable). It includes:

  • State-by-state citations of the rules, regulations and statutes pertaining to electronically transmitted, faxed or printed prescriptions
  • Authentication requirements for faxed prescriptions
  • Addresses, Web sites and contact information
  • Actionable spreadsheet summarizing each Board's requirements
  • Indication of which states require written and/or in-person approval

"State pharmacy-related regulations and statutes are forever changing and are often ambiguous. That's why persistent monitoring and in-depth analysis are critical," said Tony Schueth, POCP's founder and managing partner. "POCP is in a unique position to interpret and analyze the rules and regulations and to work with clients to utilize the information to further their business goals."

In addition to the compendium and its quarterly updates, Dr. Neumann and other POCP staff are available to create value-driven assessments, as well as drill down on issues specific to individual market situations, to assist product development and implementation teams. For additional information, call Tony Schueth at 954-346-1999.

SOURCE Point of Care Partners


'/>"/>
SOURCE Point of Care Partners
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
4. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
5. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
6. Newly Approved HIV Drug Shows Great Promise
7. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
8. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
9. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 2016 http://www.researchandmarkets.com/research/fqx6nz/global_skin ) ... Skin Protective Equipment Market 2016-2020" report to ... ) has announced the addition of the ... to their offering. --> ... the addition of the "Global Skin Protective ...
(Date:2/8/2016)... , Feb. 8, 2016  A research team ... scientists has discovered details of how the abnormal breakage ... a particularly aggressive form of acute lymphoblastic leukemia (ALL). ... which genetic mutations trigger overproduction of immature cells, called ... The discoveries of the malfunction underlying the type called ...
(Date:2/8/2016)... -- As part of a major growth and expansion initiative, Dune ... Lori Chmura as President of Dune Inc., its U.S. ... extensive experience in the medical device space will play a ... --> --> In her ... marketing and operational functions in the U.S. She is tasked ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... 08, 2016 , ... Stephanie Hebert Insurance Agency, serving families ... new charity campaign. As part of their ongoing community involvement program, funds are ... that children deserve a voice, and in the spirit of neighbors helping neighbors ...
(Date:2/8/2016)... ... 2016 , ... Tingley Rubber Corporation , a leading ... range of unique and advantaged protective solutions to a growing and dynamic ... customer service and marketing support. A new distribution center in Brampton, Ontario will ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... networking and relationship-marketing firm, announced today that nominations will be accepted February ... (ISE®) West Awards. , Awards include the Information Security Executive® of ...
(Date:2/8/2016)... ... 2016 , ... GrassrootsHealth published data from its D*action public ... in the GrassrootsHealth cohort with substantially higher vitamin D levels than a cohort ... states Carole Baggerly, Director of GrassrootsHealth, “the safety and benefits of vitamin ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... The ... annually in this country. The AutismOne 2016 Conference, which is being held May 25-29 ... often won’t hear elsewhere about helpful interventions and causes of chronic illness in children. ...
Breaking Medicine News(10 mins):